Onychomycosis is the most common nail disease and describes the invasion of the nail by fungi. In most cases, treatment of onychomycosis requires systemic antifungals, with duration of administration ranging from 2 to several months. Cure rates range from 60% to 80%, and relapses are not rare (up to 20% of patients). New antifungals providing higher cure rates and less relapses are, therefore, auspicable. A review of onychomycoses and their treatment is made and the new antifungal drugs that are currently on study or already available are presented
Piraccini BM, Iorizzo M, Rech G, Tosti A (2006). Emerging agents for onychomycosis. GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 141, 155-159.
Emerging agents for onychomycosis
PIRACCINI, BIANCA MARIA;IORIZZO, MATILDE;RECH, GIULIA;TOSTI, ANTONELLA
2006
Abstract
Onychomycosis is the most common nail disease and describes the invasion of the nail by fungi. In most cases, treatment of onychomycosis requires systemic antifungals, with duration of administration ranging from 2 to several months. Cure rates range from 60% to 80%, and relapses are not rare (up to 20% of patients). New antifungals providing higher cure rates and less relapses are, therefore, auspicable. A review of onychomycoses and their treatment is made and the new antifungal drugs that are currently on study or already available are presentedI documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
